Company / Working Capital
Twist Bioscience Corp Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$241.6M
FY2025
5-year range
$241.6M / $505.8M
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
#163 of 215
Health Care
What the data says
Twist Bioscience Corp's working capital of $242M is lower than 76% of companies in the Health Care sector (FY2025). Working Capital has declined for 3 consecutive years, from $506M in FY2022 to $242M in FY2025.
Based on SEC 10-K filings.
$242M in FY2025 with a 5-year CAGR of -4.2%.
Declined from $351M to $242M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -21.8%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 215This company $241.6M Sector average $957.8M
▼
-74.8% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's working capital has declined for 3 consecutive years.
- 5-year CAGR of -4.2%, indicating a declining trend.
- In FY2025, working capital decreased 12.4% year-over-year.
- Ranks #163 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $241.6M | -12.4% |
| FY2024 | $275.8M | -21.4% |
| FY2023 | $350.9M | -30.6% |
| FY2022 | $505.8M | +4.6% |
| FY2021 | $483.4M | +61.8% |
| FY2020 | $298.8M | +130.3% |
| FY2019 | $129.8M | +68.3% |
| FY2018 | $77.1M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026